Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-08-23
2005-08-23
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S716000, C514S721000
Reexamination Certificate
active
06933321
ABSTRACT:
Biphenyl derivatives are disclosed for use in the treatment of androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, precocious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness. For example, some preferred compounds having the structure:are formulated together with pharmaceutically acceptable diluent or carrier for topical use in the treatment of acne, hirutism, seborrhea or androgenic alopecia, or for systemic use in the treatment of androgen-dependent prostate cancer.
REFERENCES:
patent: 3281280 (1966-10-01), Schaefer
patent: 3742951 (1973-07-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 4285829 (1981-08-01), Eidenschink et al.
patent: 4568343 (1986-02-01), Leeper et al.
patent: 5064654 (1991-11-01), Berner et al.
patent: 5071644 (1991-12-01), Viegas et al.
patent: 5071657 (1991-12-01), Oloff et al.
patent: 5518654 (1996-05-01), Coates
patent: 5559277 (1996-09-01), Beller et al.
patent: 6060503 (2000-05-01), Labrie et al.
patent: 32 47 215 (1984-06-01), None
patent: 196 07 135 (1997-04-01), None
patent: 0 279 982 (1988-08-01), None
patent: 0 757 982 (1997-02-01), None
patent: 05-273771 (1993-10-01), None
patent: WO 94 05153 (1994-03-01), None
patent: WO 94 25431 (1994-10-01), None
patent: WO-99/55668 (1999-11-01), None
patent: WO 01 70678 (2001-09-01), None
Database CA 'Online! Chemical Abstracts Service, Columbus, Ohio, US; Toyama, Takeshi et al: “Biaryl compounds and diaryl ethers as uricosuric agents” retrieved from STN, Database accession No. 132:73651, XP002237333, see compound RN= 42289-54-3, abstract & JP 2000 001431 A (Kotobuki Seiyaku Co., Ltd., Japan) Jan. 7, 2000.
Database CA 'Online! Chemical Abstracts Service, Columbus, Ohio, US; Parkinson, Andrew et al: “Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorobiphenyls” retrieved from STN, Database accession No. 110:149290, XP002237334, See compound RN=88966-74-9 abstract & Toxicology (1988), 53(2-3), 289-300.
American Chemical Society Division of Medicinal Chemistry, Abstracts, 222ndACS National Meeting, Chicago, IL, Aug. 26-30, 2001, No. 201. “Synthesis and SAR of 5-aryl Oxindoles and 5-aryl Indolines as Novel Non-Steroidal PR Antagonists”, John W. Ullrich, et al.
American Chemical Society Division of Medicinal Chemistry, Abstracts, 222ndACS National Meeting, Chicago, IL, Aug. 26-30, 2001, No. 204. “Structure Activity Relationship of Triaryl and Biaryl Carboxy Acid and Acylsulfonamide Analogs on the Human EP3Prostano Receptor”, Michel Gallant, et al.
Online!, J. Biol. Chem. vol. 277, Issue 32, 28909-28915, Aug. 9, 2002, Evidence That the Human Gene for Prostate Short-chain Dehydrogenase/Reductase (PSDRI) Encodes a Novel Retinal Reductase (RAIRI), Natalia Y. Kedishvili, et al.
Bioorganic & Medicinal Chemistry Letters II (2001), pp. 1709-1712 “Biphenyls as Surrogates of the Steroidal Backbone. Part 1: Synthesis and Estrogen Receptor Affinity of an Original Series of Polysubstituted Biphenyls”, Dominique Lesuisse, et al.
Bioorganic & Medicinal Chemistry Letters II (2001), pp. 1713-1716 “Biphenyls as Surrogates of the Steroidal Backbone. Part 2: Discovery of a Novel Family of Non-steroidal 5-α-Reductase Inhibitors”, Dominique Lesuisse, et al.
Online—Cancer Research 61, pp. 1611-1618, Feb. 15, 2001, American Association for Cancer Research, Molecular Biology and Genetics “Prostrate Short-Chain Dehydrogenase Reductase 1 (PSDRI): A New Member of the Short-Chain Steroid Dehydrogenase/Reductase Family Highly Expressed in Normal and Neoplastic Prostate Epithelium”, Biaoyang Lin, et al.
J. Med. Chem. 2000, 43, pp. 4354-4358, “Biarylpropysulfonamides as Novel, Potent Potentiators of 2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors”, Paul L. Ornstein, et al.
“Apparent Positive Cooperative Effects in Cyclic AMP and Corticosterone Production by Isolated by Adrenal Cells in Response to ACTH Analogues”, (1974) Endocrinology vol. 94, No. 5, pp. 1427-1437, D. Robard, (Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014).
Bioorganic & Medicinal Chemistry 8 (2000) pp. 1087-1109, “Biaryl Diacid Inhibitors of Human s-PLA2with Anti-Inflammatory Activity”, Dane M. Springer, et al.
Medline, “Development of methods for the quantitative in vitro analysis of androgen-dependent and autonomous Shionogi carcinoma 115 cells”, E.R. Stanley, et al., Abstract.
Bioorganic & Medicinal Chemistry 8 (2000), pp. 1245-1252, Novel Imidazolyl and Triazolyl Substituted Biphenyl Compounds: Synthesis and Evaluation as Nonsteroidal Inhibitors of Human 17α-Hydroxylase-C17, 20-Lyase (P450 17), Yan Zhuang, et al.
Labrie Fernand
Luu-The Van
Singh Shankar Mohan
Endorecherche Inc.
Ostrolenk Faber Gerb & Soffen, LLP
Powers Fiona T.
LandOfFree
Antiandrogenic biphenyls does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiandrogenic biphenyls, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiandrogenic biphenyls will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517095